| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3201/EID1902.120941 |
| P8608 | Fatcat ID | release_6i5nlc3d6vcn3lhmqttkcq4pza |
| P932 | PMC publication ID | 3559053 |
| P698 | PubMed publication ID | 23347653 |
| P5875 | ResearchGate publication ID | 235370088 |
| P50 | author | David L. Heymann | Q5236204 |
| Osman Dar | Q83388150 | ||
| P2093 | author name string | Sue Hogarth | |
| Sabrina McIntyre | |||
| P2860 | cites work | The 2007 Rift Valley fever outbreak in Sudan | Q27026883 |
| Rift Valley Fever Outbreak, Mauritania, 1998: Seroepidemiologic, Virologic, Entomologic, and Zoologic Investigations | Q27487840 | ||
| Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics | Q33357041 | ||
| Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention | Q33960690 | ||
| An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007 | Q34034053 | ||
| Prediction, Assessment of the Rift Valley Fever Activity in East and Southern Africa 2006–2008 and Possible Vector Control Strategies | Q34034069 | ||
| An Assessment of the Regional and National Socio-Economic Impacts of the 2007 Rift Valley Fever Outbreak in Kenya | Q34034088 | ||
| Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
| Public health and biosecurity. Restricted data on influenza H5N1 virus transmission | Q34135519 | ||
| Rift valley fever: recent insights into pathogenesis and prevention | Q34174444 | ||
| Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. | Q34908264 | ||
| Unexpected Rift Valley fever outbreak, northern Mauritania | Q35847618 | ||
| Outbreak of Rift Valley fever--Saudi Arabia, August-October, 2000. | Q39192548 | ||
| Potential for North American mosquitoes to transmit Rift Valley fever virus | Q40398345 | ||
| Rift Valley fever outbreak--Kenya, November 2006-January 2007. | Q40458723 | ||
| Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans | Q40567114 | ||
| Influenza virus samples, international law, and global health diplomacy | Q43175843 | ||
| Rift Valley Fever--East Africa, 1997-1998. | Q46933218 | ||
| P433 | issue | 2 | |
| P921 | main subject | zoonosis | Q182672 |
| Rift Valley fever | Q326638 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 189-193 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Rift Valley fever and a new paradigm of research and development for zoonotic disease control | |
| P478 | volume | 19 |
| Q37626719 | A statistical model of Rift Valley fever activity in Egypt |
| Q34487937 | A systematic review of Rift Valley Fever epidemiology 1931-2014. |
| Q64114488 | An Overview of the Most Significant Zoonotic Viral Pathogens Transmitted from Animal to Human in Saudi Arabia |
| Q52647635 | Applications of gold nanoparticles in virus detection. |
| Q38655917 | Climate Influence on Emerging Risk Areas for Rift Valley Fever Epidemics in Tanzania |
| Q54116240 | Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication. |
| Q30208825 | Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread |
| Q35984787 | Epidemiologic and Environmental Risk Factors of Rift Valley Fever in Southern Africa from 2008 to 2011. |
| Q26314582 | Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? |
| Q38880677 | Identifying Areas Suitable for the Occurrence of Rift Valley Fever in North Africa: Implications for Surveillance |
| Q37254943 | Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. |
| Q35840960 | Knowledge, Attitudes and Practices (KAP) on Rift Valley Fever among Pastoralist Communities of Ijara District, North Eastern Kenya |
| Q40220077 | Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania |
| Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
| Q37231456 | Predicting distribution of Aedes aegypti and Culex pipiens complex, potential vectors of Rift Valley fever virus in relation to disease epidemics in East Africa |
| Q34292066 | Recent outbreaks of rift valley Fever in East Africa and the middle East |
| Q52665091 | Rift Valley Fever. |
| Q38253960 | Risk factors associated with human Rift Valley fever infection: systematic review and meta-analysis |
| Q64246621 | Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania |
| Q91656354 | Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves |
| Q36371106 | Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia |
| Q34258654 | Simulation modelling of population dynamics of mosquito vectors for rift valley Fever virus in a disease epidemic setting |
| Q37300854 | Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania |
| Q35106416 | Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007. |
| Q40076431 | Synthesis and in vitro antiviral evaluation of 4-substituted 3,4-dihydropyrimidinones. |
| Q84957526 | The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal |
| Q27468927 | Widespread Rift Valley Fever Emergence in Senegal in 2013–2014 |
Search more.